作者:Wei Huang、Yu Ding、Yan Miao、Ming-Zhen Liu、Yan Li、Guang-Fu Yang
DOI:10.1016/j.ejmech.2009.04.004
日期:2009.9
A series of chromone derivatives bearing diverse dithiocarbamate moieties were designed and synthesized via a three-component reaction protocol. Their in vitro antitumor activities were evaluated by MTT method against HCCLM-7, Hela, MDA-MB-435S, SW-480, Hep-2 and MCF-7. Two compounds (3-chloro-4-oxo-4H-chromen-2-yl)methyl piperidine-1-carbodithioate (Iq) and (6-chloro-4-oxo-4H-chromen-3-yl)methyl
通过三组分反应方案设计和合成了一系列带有不同二硫代氨基甲酸酯部分的色酮衍生物。通过MTT方法评估它们对HCCLM-7,Hela,MDA-MB-435S,SW-480,Hep-2和MCF-7的体外抗肿瘤活性。(3-氯-4-氧代-4 H-铬-2-基)甲基哌啶-1-碳二硫酸酯(I q)和(6-氯-4-氧代-4 H-铬n-3-基)甲基哌啶-1-碳二硫代乙酸盐(II u)因其高效能和广谱性而被认为是最有前途的候选物。进一步的流激活细胞分选分析表明,化合物I q和IIu抑制SW-480和MDA-MB-435s在G 2 / M期的细胞周期均具有剂量依赖性,并可能在这些肿瘤细胞系中表现出凋亡诱导作用。